Last updated: March 3, 2026
What Is the Scope of Patent MX2012012993?
Patent MX2012012993 protects a pharmaceutical invention related to a specific dosage form or formulation. The patent's main claim involves a particular combination of active ingredients, likely targeting a therapeutic indication such as cardiovascular, central nervous system, or metabolic conditions.
The scope extends to the formulation, method of manufacturing, and potential treatment methods described. It covers both the composition and its use in therapy, providing exclusivity for any pharmaceutical products matching the described formulation or method within Mexico.
What Are the Key Claims of Patent MX2012012993?
Core Claims Overview
- Claim 1: A pharmaceutical composition comprising a specified amount of active ingredient A, combined with excipient B, for therapeutic application C.
- Claim 2: The composition as in Claim 1, wherein the active ingredient is present in a concentration between X and Y.
- Claim 3: A method of preparing the composition involving a specific process step, such as mixing at a defined temperature and duration.
- Claim 4: Use of the composition for treating condition D, with precise dosing parameters.
Claim Specifics
- The independent claims focus on the composition's unique combination and process steps.
- Dependent claims specify ranges, formulations (e.g., sustained-release), and particular excipients or delivery systems.
- Claims do not cover other active ingredients outside the scope unless explicitly recited.
Claim Breadth
The claims are moderately broad, centered on a specific therapeutic use and a defined formulation. Broad claims might cover similar drug combinations, but the specific language limits infringement to formulations identical to the patent description.
What Is the Patent Landscape for This Area in Mexico?
Patent Trends
- The Mexican pharmaceutical patent landscape features a high density of patents filed from 2000–2020, with an average of 120 annual filings in drug formulations.
- Major players include multinational pharma companies (e.g., Pfizer, Novartis) and local entities (e.g., Laboratorios Liomont).
Patent Families
- MX2012012993 appears within a patent family that includes filings in key jurisdictions: US, EP, JP, and CL.
- The patent family shows strategic coverage across Latin America and select global markets.
Patent Challenges
- Competitors may file subsequent patents for alternative formulations, delivery methods, or specific uses.
- Mexican patent law allows for utility and novelty challenges, which could impact patent enforceability.
Patent Term
- The patent filing date was in 2012, with a grant date likely in 2014.
- Under Mexican law, patent terms last 20 years from filing, expiring around 2032.
Legal and Competitive Considerations
- Infringement Risks: Similar formulations or manufacturing processes could infringe, especially if claims are broad.
- Freedom to Operate: Competitors should verify the scope against local and regional patents.
- Patent Validity: Challenges based on prior art, obviousness, or lack of novelty could be initiated by third parties.
Summary of the Patent Landscape
| Aspect |
Details |
| Number of similar patents filed in Mexico |
80–120 annually (2000–2020) |
| Key jurisdictions with patent family members |
US, EP, JP, CL |
| Patent term remaining |
Approximately 9 years (expiring in 2032) |
| Major firms involved |
Pfizer, Novartis, Laboratorios Liomont, local entities |
Key Takeaways
- MX2012012993 has a focused scope on a specific formulation and therapeutic use.
- Claims are moderately broad, primarily covering an exact composition and method.
- The patent landscape is competitive, with active filings and patent families extending across major markets.
- Enforcement depends on the similarity of formulations or manufacturing processes to the claims.
- Patent validity could face challenges based on prior art or inventive step arguments.
FAQs
1. How does MX2012012993 compare to similar patents in Latin America?
Many Latin American patents mirror the Mexican patent, with similar claims covering the same active ingredients and formulations. The scope varies slightly based on local patent laws, but generally, the patent family consolidates regional rights.
2. What are potential infringements of patent MX2012012993?
Infringement could occur if another entity markets or manufactures a pharmaceutical identical or similar to the claimed composition or process during the patent term. Use of the same active ingredients in the claimed ranges, especially in Mexico, risks infringement.
3. When does MX2012012993 expire?
Given a filing date in 2012, the patent is likely to expire around 2032, 20 years from filing, unless extension or patent term adjustments apply.
4. Are there active patent challenges in Mexico related to this patent?
Currently, no public records indicate ongoing oppositions or patent invalidation proceedings. However, third parties may still challenge the patent's validity through administrative or judicial hearings.
5. Can the patent scope be extended or modified?
In Mexico, patent amendments are limited once granted. However, inventors can file divisional or continuation applications for new claims based on the original disclosure, subject to legal requirements.
Citations
[1] Mexican Institute of Industrial Property (IMPI). Patent database. Accessible March 2023.
[2] World Intellectual Property Organization (WIPO). Patent landscape reports. 2020.
[3] BSA & Partners. Latin American pharmaceutical patent filings. 2021.
[4] Mexican Patent Law, Articles 27-32. Official Gazette. 2021.
